Bimatoprost ophthalmic solution (Aequus Pharmaceuticals)

N/A

Report date: 2025/05/29 14:59:39

Base Information

Drug NameBimatoprost ophthalmic solution (Aequus Pharmaceuticals)
Drug Alias NameZIMED PF
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid receptor agonists
TargetsProstanoid receptor
Therapy Area/IndicationsGlaucoma, Open-Angle
Global Approved IndicationsGlaucoma, Open-Angle
Approved Indications in ChinaN/A
Original Approved Country/TerritoryCanada
Original Approved Date2022/12/13
Country/TerritoryCanada
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAequus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAequus Pharmaceuticals IncLuvo Medical Technologies Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-Angle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A